Dec. 28, 2006 – Rimonabant is a CB1-Rezeptor blocker. It normalizes the overactivity of the Endocannabinoid of system.
Rimonabant should be used only with strong predominance (BMI = 30), if calorie-poor food, change of the eating habits and the movement did not have the desired effect and additional factors of risk for heart cycle illnesses to exist as for instance diabetes type of 2 or high blood fat values.
For more info visit : http://acomplia.virtuale.org/acomplia_italia.html
— End —